ArticleWorld journal of gastroenterology2006

Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer.

Alexander Huether et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.